This is a non-core endpoint: only basic statistics are computed.
Injury of blood vessels at ankle and foot level
ST19_INJURY_BLOOD_VESSE_ANKLE_FOOT_LEVEL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
41 |
4. Check minimum number of eventsNone |
41 |
5. Include endpointsNone |
41 |
6. Filter based on genotype QC (FinnGen only) |
41 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesio vasorum sanguineorum in regione tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Injury of blood vessels at ankle and foot level
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Paracetamol of NSAID medication
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 41 | 17 | 24 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 52.43 | 57.19 | 49.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
22
106
3.32
3.47
2.7
2.8
—
—
—
0
0
11
35
3.93
3.20
5.4
20.5
5.1
4.9
kpa
0.41
11
35
11
35
3.93
3.20
5.4
20.6
13.6
12.5
kpa
0.21
11
35
27
155
3.17
3.05
2.5
3.9
0.0
0.0
estimate
—
8
28
27
155
3.17
3.05
3.1
5.4
0.0
0.0
estimate
—
7
27
27
157
3.11
2.95
2.5
3.9
0.0
0.0
estimate
—
8
24
24
131
3.01
2.93
2.2
3.9
—
—
—
0
0
7
15
5.39
2.73
5.3
4.3
25.7
25.1
mmol/l
—
7
15
24
138
2.78
2.56
10.1
9.9
1.2
1.2
mmol/l
0.64
19
112
8
22
4.25
2.52
6.0
9.1
1.7
1.5
%
—
8
22
11
41
3.30
2.51
7.3
7.5
105.6
103.1
mmol/l
0.99
11
41
6
12
5.65
2.50
7.5
13.8
23.8
24.1
mmol/l
—
6
12
7
21
3.80
2.07
1.1
1.7
—
—
—
0
0
7
29
2.70
1.46
1.7
1.5
—
—
—
0
0
12
63
2.28
1.40
2.8
2.8
—
—
—
0
0
30
231
2.11
1.26
4.4
3.8
13.7
11.0
mm/h
0.40
30
215
5
20
2.70
1.18
4.2
1.7
0.9
1.4
%
—
5
20
7
31
2.51
1.17
2.0
1.7
—
—
—
0
0
6
30
2.17
0.91
4.8
4.0
—
—
—
0
0
9
53
1.89
0.83
3.9
3.9
2.5
2.4
mmol/l
—
9
46
19
140
1.67
0.78
4.8
4.9
—
—
—
0
0
5
24
2.23
0.77
3.8
24.9
24.8
23.9
mmol/l
—
5
24
7
40
1.90
0.76
2.0
1.9
—
—
—
0
0
15
106
1.65
0.71
2.1
2.1
92.0
101.4
pmol/l
—
6
47
10
63
1.78
0.69
1.2
1.5
—
—
—
0
0
24
195
1.56
0.62
2.8
2.9
—
—
—
0
0
20
160
1.49
0.53
5.1
8.4
11.2
10.6
umol/l
0.14
20
150
23
192
1.45
0.48
6.7
7.2
7.4
6.6
mmol/l
0.61
23
175
5
33
1.58
0.43
1.4
2.5
—
—
—
0
0
17
137
1.41
0.41
4.9
5.6
35.6
36.3
g/l
0.18
17
130
0
11
0.00
0.21
0.0
4.4
—
0.5
—
0
11
0
11
0.00
0.21
0.0
4.4
—
0.0
—
0
11
0
11
0.00
0.21
0.0
4.2
—
9.8
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
4.5
—
0.0
—
0
10
0
10
0.00
0.21
0.0
4.5
—
38.0
—
0
10
0
10
0.00
0.21
0.0
4.5
—
0.0
—
0
10
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
11
91
1.29
0.20
4.5
4.2
24.4
19.6
%
—
6
38
12
113
1.09
0.02
8.0
4.8
3.1
4.7
ug/l
0.20
12
101
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
59.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
4.3
—
33.7
—
0
8
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_BLOOD_VESSE_ANKLE_FOOT_LEVEL – Injury of blood vessels at ankle and foot level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).